Literature DB >> 11747423

Structure and function in rhodopsin: mapping light-dependent changes in distance between residue 65 in helix TM1 and residues in the sequence 306-319 at the cytoplasmic end of helix TM7 and in helix H8.

C Altenbach1, K Cai, J Klein-Seetharaman, H G Khorana, W L Hubbell.   

Abstract

Spin-labeled double mutants of rhodopsin were produced containing a reference nitroxide at position 65, at the cytoplasmic termination of helix TM1, and a second nitroxide in the sequence of residues 306-319, which includes the cytoplasmic termination of helix TM7 and nearly the entire surface helix H8. Magnetic dipole-dipole interactions between the spins are analyzed to provide interspin distance distributions in both the dark and photoactivated states of rhodopsin. The distributions, apparently resulting from the conformational flexibility of the side chains, are found to be consistent with the structural model of rhodopsin in the dark state derived from crystallography. Photoactivation of the receptor triggers an increase in distance between residues in TM7, but not those in H8, relative to the reference at position 65 in TM1. The simplest interpretation of the result is a movement of the cytoplasmic portion of TM7 away from TM1 by 2-4 A.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747423     DOI: 10.1021/bi011546g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  32 in total

1.  Initial structural and dynamic characterization of the M2 protein transmembrane and amphipathic helices in lipid bilayers.

Authors:  Changlin Tian; Philip Fei Gao; Lawrence H Pinto; Robert A Lamb; Timothy A Cross
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

2.  Helix 8 plays a crucial role in bradykinin B(2) receptor trafficking and signaling.

Authors:  Jens Feierler; Markus Wirth; Benjamin Welte; Steffen Schüssler; Marianne Jochum; Alexander Faussner
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

Review 3.  Homology modeling of opioid receptor-ligand complexes using experimental constraints.

Authors:  Irina D Pogozheva; Magdalena J Przydzial; Henry I Mosberg
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

4.  Molecular dynamics of rhodopsin and free opsin: computer simulation.

Authors:  Kh T Kholmurodov; T B Fel'dman; M A Ostrovskii
Journal:  Neurosci Behav Physiol       Date:  2007-02

Review 5.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

6.  Conformational changes in the parathyroid hormone receptor associated with activation by agonist.

Authors:  Beena E Thomas; Iwona Woznica; Dale F Mierke; Angela Wittelsberger; Michael Rosenblatt
Journal:  Mol Endocrinol       Date:  2008-02-07

7.  Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics.

Authors:  Ping Zhang; Andrew J Leger; James D Baleja; Rajashree Rana; Tiffany Corlin; Nga Nguyen; Georgios Koukos; Andrew Bohm; Lidija Covic; Athan Kuliopulos
Journal:  J Biol Chem       Date:  2015-05-01       Impact factor: 5.157

8.  Concerted interconversion between ionic lock substates of the beta(2) adrenergic receptor revealed by microsecond timescale molecular dynamics.

Authors:  Tod D Romo; Alan Grossfield; Michael C Pitman
Journal:  Biophys J       Date:  2010-01-06       Impact factor: 4.033

9.  Structural and dynamic effects of cholesterol at preferred sites of interaction with rhodopsin identified from microsecond length molecular dynamics simulations.

Authors:  George Khelashvili; Alan Grossfield; Scott E Feller; Michael C Pitman; Harel Weinstein
Journal:  Proteins       Date:  2009-08-01

Review 10.  The crystallographic model of rhodopsin and its use in studies of other G protein-coupled receptors.

Authors:  Slawomir Filipek; David C Teller; Krzysztof Palczewski; Ronald Stenkamp
Journal:  Annu Rev Biophys Biomol Struct       Date:  2003-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.